Bamlanivimab for Prevention of COVID-19

被引：10
|
作者：
Kuritzkes, Daniel R. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2021年 / 326卷 / 01期
关键词：
D O I：
10.1001/jama.2021.7515
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [1] An EUA for Bamlanivimab and Etesevimab for COVID-19
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1621`): : 49 - 50
  • [2] An EUA for Bamlanivimab - A Monoclonal Antibody for COVID-19
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1612): : 185 - 186
  • [3] Bamlanivimab for Covid-19 in Kidney Transplant Patients
    Jan, M. Y.
    El-Sayegh, S.
    Yaqub, M. S.
    Mishler, D. P.
    Adebiyi, O.
    Anderson, M. D.
    Taber, T. E.
    Sharfuddin, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 861 - 862
  • [4] Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
    Destras, Gregory
    Assaad, Souad
    Bal, Antonin
    Bouscambert-Duchamp, Maude
    Avrillon, Virginie
    Simon, Bruno
    Valette, Martine
    Blay, Jean-Yves
    Lina, Bruno
    Frobert, Emilie
    Josset, Laurence
    [J]. LANCET MICROBE, 2021, 2 (09): : 424 - 424
  • [5] Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
    Dougan, M.
    Nirula, A.
    Azizad, M.
    Mocherla, B.
    Gottlieb, R. L.
    Chen, P.
    Hebert, C.
    Perry, R.
    Boscia, J.
    Heller, B.
    Morris, J.
    Crystal, C.
    Igbinadolor, A.
    Huhn, G.
    Cardona, J.
    Shawa, I
    Kumar, P.
    Adams, A. C.
    Van Naarden, J.
    Custer, K. L.
    Durante, M.
    Oakley, G.
    Schade, A. E.
    Holzer, T. R.
    Ebert, P. J.
    Higgs, R. E.
    Kallewaard, N. L.
    Sabo, J.
    Patel, D. R.
    Dabora, M. C.
    Klekotka, P.
    Shen, L.
    Skovronsky, D. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15): : 1382 - 1392
  • [6] Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database
    Zhao, Yunfei
    Wang, Huiling
    Zhang, Qingsong
    Hu, Yongxin
    Xu, Yulong
    Liu, Wei
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (04) : 331 - 338
  • [7] Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
    Jan, Muhammad Y.
    Sayegh, Skye E.
    Webb, Hanna T.
    Adebiyi, Oluwafisayo
    Anderson, Melissa D.
    Mishler, Dennis P.
    Yaqub, Muhammad S.
    Taber, Tim
    Sharfuddin, Asif A.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (09): : 2468 - 2471
  • [8] Bamlanivimab and Etesevimab for Post-Exposure Prophylaxis of COVID-19
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1635): : 163 - 164
  • [9] Improved Mortality in COVID-19 Kidney Transplant Recipients Treated with Bamlanivimab
    Hamiduzzaman, A.
    Reddy, U.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 778 - 778
  • [10] Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1359 - 1362
12345